Bachem Holding AG (LON: 0QND)

Market Cap	4.01B
Revenue (ttm)	508.76M
Net Income (ttm)	100.00M
Shares Out	n/a
EPS (ttm)	1.34
PE Ratio	40.08
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Apr 26, 2024

Volume	90
Average Volume	7,830
Open	59.60
Previous Close	59.75
Day's Range	59.60 - 59.60
52-Week Range	54.70 - 105.30
Beta	0.72
RSI	35.87
Earnings Date	Feb 27, 2025

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1971
• Employees: 2,006
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QND

Financial Performance

In 2023, Bachem Holding AG's revenue was 577.32 million, an increase of 8.57% compared to the previous year's 531.74 million. Earnings were 111.86 million, an increase of 11.10%.

Financial numbers in CHF